K Butz
Overview
Explore the profile of K Butz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
562
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Crnkovic-Mertens I, Wagener N, Semzow J, Grone E, Haferkamp A, Hohenfellner M, et al.
Cell Mol Life Sci
. 2007 Apr;
64(9):1137-44.
PMID: 17437058
Cancer cells are typically characterized by apoptosis deficiency. In order to investigate a possible role for the anti-apoptotic livin gene in renal cell cancer (RCC), we analyzed its expression in...
2.
Vogt M, Butz K, Dymalla S, Semzow J, Hoppe-Seyler F
Oncogene
. 2006 Feb;
25(29):4009-15.
PMID: 16462759
Oncogenic types of human papillomaviruses (HPVs) cause cervical cancer in humans. The antiapoptotic viral E6 gene has been identified as a key factor for maintaining the viability of HPV-positive cancer...
3.
Klevenz B, Butz K, Hoppe-Seyler F
Cell Mol Life Sci
. 2003 Jan;
59(11):1993-8.
PMID: 12530529
Peptide aptamers have emerged as powerful new tools for molecular medicine. They can specifically bind to and functionally inactivate a given target molecule under intracellular conditions. Typically, peptide aptamers are...
4.
Graefen M, Pichlmeier U, Hammerer P, Haese A, Butz K, Erbersdobler A, et al.
Prostate Cancer Prostatic Dis
. 2002 Dec;
3(S1):S18.
PMID: 12497128
No abstract available.
5.
Butz K, Denk C, Fitscher B, Crnkovic-Mertens I, Ullmann A, Schroder C, et al.
Oncogene
. 2001 Oct;
20(45):6579-86.
PMID: 11641783
A substantial proportion of the worldwide liver cancer incidence is associated with chronic hepatitis B virus (HBV) infection. The therapeutic management of HBV infections is still problematic and novel antiviral...
6.
Hoppe-Seyler F, Crnkovic-Mertens I, Denk C, Fitscher B, Klevenz B, Tomai E, et al.
J Steroid Biochem Mol Biol
. 2001 Sep;
78(2):105-11.
PMID: 11566434
The ability to specifically interfere with the function of proteins of pathological significance has been a goal for molecular medicine for many years. Peptide aptamers comprise a new class of...
7.
Beger M, Butz K, Denk C, Williams T, Hurst H, Hoppe-Seyler F
J Mol Med (Berl)
. 2001 Aug;
79(5-6):314-20.
PMID: 11485026
The AP-2 family of transcription factors consists of three known members, namely AP-2alpha, AP-2beta, and AP-2gamma. In experimental systems AP-2 factors possess tumor suppressor-like activities, and alterations in the AP-2...
8.
Denk C, Butz K, Schneider A, Durst M, Hoppe-Seyler F
J Mol Med (Berl)
. 2001 Aug;
79(5-6):283-8.
PMID: 11485021
Mutations of the p53 gene have been shown to be associated with aggressive growth behavior and increased recurrence rates for certain tumors. Primary cervical cancers contain oncogenic human papillomaviruses (HPV)...
9.
Graefen M, Haese A, Pichlmeier U, Hammerer P, Noldus J, Butz K, et al.
J Urol
. 2001 Feb;
165(3):857-63.
PMID: 11176486
Purpose: Nerve sparing radical prostatectomy for prostate cancer should be restricted to patients who harbor tumors without capsular penetration. To our knowledge the selection criteria for nerve sparing radical prostatectomy...
10.
Hoppe-Seyler F, Butz K
J Mol Med (Berl)
. 2000 Nov;
78(8):426-30.
PMID: 11097111
One of the major goals in molecular medicine is to understand the basis of human diseases at the molecular level and to translate this information into new strategies for diagnosis...